News for LeMaitre Vascular, Inc. (LMAT)

**media[583165]**

Shares of LeMaitre Vascular Inc (LMAT) fell 2.56% in mid-day trading on Mar 22. The stock reached an intraday low of $82.52, before recovering slightly to $83

GARDNER, Mass., March 20, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. ( POCI), a leading designer and manufacturer of advanced optical instrum

On March 4, 2025, Lawrence Jasinski, Director at LeMaitre Vascular Inc (LMAT), sold 3,142 shares of the company, as reported in a SEC Filing. Following this tra

Mr. Paul Mullen Most Recently Served as the Director of Sales at Inari Medical which was Acquired by Stryker Corporation Earlier This Year This Appointment Rep

**media[556936]**

LeMaitre Vascular Inc (LMAT), a leading provider of devices and services for the treatment of peripheral vascular disease, announced on March 3, 2025, that its

BURLINGTON, Mass., March 03, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upc

**media[556130]**

LeMaitre Vascular Inc (LMAT) showcases robust growth with a focus on niche vascular products and strategic acquisitions.LMAT's strong market presence in biolog

Shares of LeMaitre Vascular Inc (LMAT) fell 7.77% in mid-day trading on Feb 28. The stock reached an intraday low of $88.00, before recovering slightly to $92

Oppenheimer has downgraded LeMaitre Vascular (LMAT) to perform from outperform because its price target of $93 has been met.  Read more here.

Release Date: February 27, 2025For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points LeMaitre Vas

LeMaitre Vascular Inc (LMAT), a leading provider of devices and services for the treatment of peripheral vascular disease, has announced that it will release it

BURLINGTON, Mass., Jan. 27, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (LMAT) announced today that it will release its fourth quarter 2024 financial res

Transaction Overview On December 31, 2024, Copeland Capital Management, LLC (Trades, Portfolio) made a strategic decision to reduce its holdings in LeMaitre Vas

LeMaitre Vascular stock has fallen back from recent highs, but still is up just over 65% over the past 12 months. Read why I would not buy the dip in LMAT.

On December 31, 2024, Conestoga Capital Advisors, LLC (Trades, Portfolio) made a strategic decision to reduce its holdings in LeMaitre Vascular Inc (LMAT) by 15

Dow Jones dips as Nvidia shares drop, while Honeywell experiences a notable rise.